These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 619948)

  • 1. A comparison of some physiological and psychological effects of Motival (fluphenazine and nortriptyline) and diazepam in normal subjects.
    Ashton H; Millman JE; Telford R; Thompson JW
    Br J Clin Pharmacol; 1978 Feb; 5(2):141-7. PubMed ID: 619948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of some physiological and psychological effects of propranolol and diazepam in normal subjects.
    Ashton H; Millman JE; Telford R; Thompson JW
    Br J Clin Pharmacol; 1976 Aug; 3(4):551-9. PubMed ID: 22216493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological studies of fluphenazine and nortriptyline in combination in man.
    Glegg AM; Turner P
    J Pharm Pharmacol; 1971 Feb; 23(2):133-4. PubMed ID: 4396873
    [No Abstract]   [Full Text] [Related]  

  • 4. A review of clinical studies with combinations of fluphenazine and nortriptyline.
    Pigott PV
    Curr Med Res Opin; 1972; 1(1):26-36. PubMed ID: 4589400
    [No Abstract]   [Full Text] [Related]  

  • 5. Separate and combined anxiolytic and anti-depressant treatment of mixed anxiety/depression. A double-blind, placebo controlled comparison. Sussex Clinical Trials Group.
    Acta Psychiatr Scand; 1985 Jul; 72(1):81-8. PubMed ID: 2863922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluphenazine/nortriptyline in the irritable bladder syndrome. A double-blind placebo controlled study.
    Martin MR; Schiff AA
    Br J Urol; 1984 Apr; 56(2):178-9. PubMed ID: 6388713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once daily administration of a fluphenazine/nortriptyline preparation in the treatment of mixed anxiety/depressive states.
    Brodie NH; McGhie RL; O'Hara H; O'Hara J; Rodway AE; Valle-Jones JC; Schiff AA
    Curr Med Res Opin; 1976; 4(5):346-52. PubMed ID: 795608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personality traits influence the effects of diazepam and caffeine on CNV magnitude.
    Münte TF; Heinze HJ; Künkel H; Scholz M
    Neuropsychobiology; 1984; 12(1):60-7. PubMed ID: 6514179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motival in the treatment of anxiety, with or without depression.
    Grozier ML
    Psychosomatics; 1972; 13(2):109-16. PubMed ID: 4604794
    [No Abstract]   [Full Text] [Related]  

  • 10. Once-daily treatment for mixed anxiety/depressive states: a comparison of slow release amitriptyline and fluphenazine with nortriptyline.
    Magnus RV; Schiff AA
    J Int Med Res; 1977; 5(2):109-13. PubMed ID: 873028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of anxiety/depressive conditions in the elderly: a double-blind comparative study of Motival and amitriptyline.
    Sinclair JM; Walsh MR; Valle-Jones JC; Schiff AA
    Age Ageing; 1975 Nov; 4(4):226-31. PubMed ID: 803187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of fluphenazine with nortriptyline in anxiety and depression.
    Anderson J; Lambert NG; Pigott PV
    Practitioner; 1972 Apr; 208(246):511-7. PubMed ID: 4555519
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of amitriptyline and a fluphenazine/nortriptyline preparation in anxiety-depressive states.
    Bennie EH; Schiff AA
    Scott Med J; 1976 Oct; 21(4):204-9. PubMed ID: 793005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of diazepam, chlorpromazine and amobarbital on the contingent negative variation.
    Kuda K
    Folia Psychiatr Neurol Jpn; 1977; 31(1):77-87. PubMed ID: 558950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elamol and Motival-new psychotropic drugs?
    Drug Ther Bull; 1972 Oct; 10(21):83-4. PubMed ID: 4656671
    [No Abstract]   [Full Text] [Related]  

  • 16. Motival in the treatment of anxious depression.
    Faleni R; Cia A
    Curr Ther Res Clin Exp; 1972 Aug; 14(8):461-9. PubMed ID: 4629308
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical and physiological assessment of chlorazepate, diazepam and placebo in anxious neurotics.
    Lapierre YD
    Int J Clin Pharmacol Biopharm; 1975 Jun; 11(4):315-22. PubMed ID: 239907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A test of the concept of "underlying depressive illness" in the treatment of anxiety states.
    Walsh MR; Dunckley HG; Sinclair JM; Schiff AA
    Curr Med Res Opin; 1976; 4(5):340-5. PubMed ID: 12915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doctor's versus patient's judgement in the assessment of mixed anxiety/depressive illness. Implications for measurement of therapeutic response.
    Valle-Jones JC; O'Hara J; O'Hara H; McGhie RL; Brodie NH; Anderson JA; Schiff AA
    Acta Psychiatr Scand; 1981 May; 63(5):416-24. PubMed ID: 7032221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of unstable detrusor (irritable bladder) using fluphenazine and nortriptyline: progress report.
    Martin MR; James ED
    Prog Clin Biol Res; 1981; 78():335-8. PubMed ID: 7038710
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.